US Patent Issued to Iterion Therapeutics on March 11 for "Formulations of tegavivint and related compounds" (North Carolina, Pennsylvania, Texas Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,246,010, issued on March 11, was assigned to Iterion Therapeutics Inc. (Houston).

"Formulations of tegavivint and related compounds" was invented by Steven David Dykstra (Apex, N.C.), Henry Havel (Houston), Stephen Horrigan (Houston), Roger Harrison (Houston), Jeffrey Larson (Houston), Jonathan Northrup (Houston), Theodore Laslo (Wind Gap, Pa.) and Garry Gwozdz (Jim Thorpe, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Formulations of tegavivint and related compounds, methods of making such formulations and methods of treating various conditions utilizing such formulations."

The patent was filed on Feb. 25, 2022, under Application No. 17/681,132....